Cargando…
Determinants of generic drug substitution in Switzerland
BACKGROUND: Since generic drugs have the same therapeutic effect as the original formulation but at generally lower costs, their use should be more heavily promoted. However, a considerable number of barriers to their wider use have been observed in many countries. The present study examines the inf...
Autores principales: | Decollogny, Anne, Eggli, Yves, Halfon, Patricia, Lufkin, Thomas M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038892/ https://www.ncbi.nlm.nih.gov/pubmed/21269426 http://dx.doi.org/10.1186/1472-6963-11-17 |
Ejemplares similares
-
Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison
por: Halfon, Patricia, et al.
Publicado: (2013) -
Measuring medically unjustified hospitalizations in Switzerland
por: Eggli, Yves, et al.
Publicado: (2022) -
Determinants of new drugs prescription in the Swiss healthcare market
por: Decollogny, Anne, et al.
Publicado: (2018) -
Determinants of drug expenditure in the Swiss healthcare market in 2006
por: Eggli, Yves, et al.
Publicado: (2022) -
Comparing potentially avoidable hospitalization rates related to ambulatory care sensitive conditions in Switzerland: the need to refine the definition of health conditions and to adjust for population health status
por: Eggli, Yves, et al.
Publicado: (2014)